Baxter Healthcare Corporation: Cefazolin In Dextrose, Injection, Usp
Baxter is recalling a specific lot of Cefazolin in Dextrose Injection (an antibiotic medication) because cardboard particles were found in some bags. The affected product is Lot LD175708 with an expiration date of February 14, 2027. This recall applies to the 2G/100ML single-dose infusion bags.
- Recalling firm
- Baxter Healthcare Corporation
- Product
- Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.
- Reason
- Presence of Particulate Matter
- Classification
- Class I
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-07-24
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- US Nationwide.
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/3fe113c3-d0de-406b-bd33-1a267e7a6a57